{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:19:07Z","timestamp":1780924747355,"version":"3.54.1"},"publisher-location":"Berlin, Heidelberg","reference-count":10,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642626760","type":"print"},{"value":"9783642563522","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002]]},"DOI":"10.1007\/978-3-642-56352-2_18","type":"book-chapter","created":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T20:34:50Z","timestamp":1304541290000},"page":"149-153","source":"Crossref","is-referenced-by-count":33,"title":["Infusional CDE with Rituximab for the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin\u2019s Lymphoma: Preliminary Results of a Phase I\/II Study"],"prefix":"10.1007","author":[{"given":"U.","family":"Tirelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nigra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. L.","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Liberati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Benci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Sparano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1182\/blood.V96.13.4084","volume":"96","author":"AM Levine","year":"2000","unstructured":"Levine AM, Seneviratne L, Espina BM, Rock Wohl A, Tulpule A, Nathwani BN, Gill PS (2000) Evolving characteristics of AIDS-related lymphoma. Blood 96:4084\u20134090","journal-title":"Blood"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The Non-Hodgkins Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project (1993) Development of a predictive model for aggressive lymphoma: the International NHL Prognostic Factors Project. N Engl J Med 329:987\u2013994","journal-title":"N Engl J Med"},{"key":"18_CR3","first-page":"A32","volume":"21","author":"U Tirelli","year":"1999","unstructured":"Tirelli U, Spina M, Gabarre J et al (1999) Treatment of HIV-related non-Hodgkin\u2019s lymphoma adapted to prognostic factors (abstract). Third National AIDS Malignancy Conference, Bethesda, MD. J AIDS 21:A32","journal-title":"J AIDS"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","volume":"336","author":"LD Kaplan","year":"1997","unstructured":"Kaplan LD, Straus DJ, Testa MA et al (1997) Low dose chemotherapy with standard dose m-BACOD chemotherapy for non-Hodgkin\u2019s lymphoma asso-ciated with human immunodeficiency virus infection. N Engl J Med 336:1641\u20131648","journal-title":"N Engl J Med"},{"key":"18_CR5","first-page":"A32","volume":"21","author":"L Ratner","year":"1999","unstructured":"Ratner L Redden D, Hamzeh F et al (1999) Chemotherapy for HIV-associated non-Hodgkin\u2019s lymphoma in combination with highly active antiretroviral therapy (HAART) is not associated with excessive toxicity (abstract). Third National AIDS Malignancy Conference, Bethesda, MD. J AIDS 21:A32","journal-title":"J AIDS"},{"key":"18_CR6","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1200\/JCO.1996.14.11.3026","volume":"14","author":"JA Sparano","year":"1996","unstructured":"Sparano JA, Wiernik PH, Hu X, Sarta C, Schwartz EL, Soeiro R, Henry DH, Mason B, Ratech H, Dutcher IP (1996) Pilot trial of infusional cyclophospha-mide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma. J Clin Oncol 14:3026\u20133035","journal-title":"J Clin Oncol"},{"key":"18_CR7","unstructured":"Sparano JA, Lee S, Chen M, Hamilton S, Einzig AL, Ambinder RF, Henry DH, VonRoenn J (1999) Phase II trial of infusional cyclophosphamide, doxorubi-cin, and etoposide (CDE) in HIV-associated non-Hodgkin\u2019s lymphoma: an Eastern Cooperative Oncology Group trial (E1494). Meeting of the American Society of Clinical Oncology 1999 (Proceedings). J Clin Oncol 17 [Suppl 1]: abstr 41"},{"key":"18_CR8","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"D Maloney","year":"1997","unstructured":"Maloney D (1997) IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin\u2019s lymphoma. Blood 90:2188\u20132195","journal-title":"Blood"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","volume":"17","author":"MS Czuczman","year":"1999","unstructured":"Czuczman MS, Grillo-Lopez AJ, White CA, Saleh M, Gordon L, LoBuglio AF, Jonas C, Klippenstein D, Dallaire B, Yarns C (1999) Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17:268\u2013276","journal-title":"J Clin Oncol"},{"key":"18_CR10","first-page":"223","volume":"96","author":"B Coiffier","year":"2000","unstructured":"Coiffier B, Lepage E, Herbrecht R, Tilly H, Solal-Celigny P, Munck JN, Bouab-dallah R, Lederlin P, Sebban C, Morel R Naioun C, Salles G, Molina T, Gissel-brecht C (2000) Mabthera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large B-cell lymphoma (DLCL): interim re-sults of a randomized GELA trial (abstract). Blood 96:223","journal-title":"Blood"}],"container-title":["Recent Results in Cancer Research","Immunosurveillance, Immunodeficiencies and Lymphoproliferations"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-56352-2_18.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T03:07:36Z","timestamp":1606187256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-56352-2_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"ISBN":["9783642626760","9783642563522"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-56352-2_18","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}